Statins May Lower Cancer Risk by Blocking Chronic Inflammation Pathway: New Study Reveals
Boston, Massachusetts – A recent study suggests that the use of common cholesterol-lowering drugs, known as statins, may potentially reduce the risk of cancer development. The research conducted by the Mass General Cancer Center found that statins could target a pathway involved in cancer formation due to chronic inflammation in the body. Dr. Shawn Demehri, the senior author of the study, highlighted the significance of chronic inflammation as a leading cause of cancer globally. The …